Screener
Enovis ENOV Prevention & Recovery — Other Cost and Expense, Operating
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Enovis in its filing.
Tagged under the XBRL concept us-gaap:OtherCostAndExpenseOperating.
The source filing: Enovis’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001420800-26-000035
| Line item | Three Months Ended / July 3, 2026 | Three Months Ended / July 4, 2025 | Six Months Ended / July 3, 2026 | Six Months Ended / July 4, 2025 |
|---|---|---|---|---|
| Net sales | $288,248 | $290,570 | $560,266 | $563,154 |
| Segment cost of sales | 124,094 | 131,336 | 249,851 | 260,100 |
| Segment research and development | 7,706 | 9,669 | 15,453 | 18,910 |
| Segment operating expense | 111,250 | 107,523 | 223,720 | 215,367 |
| Total segment expenses | 243,050 | 248,528 | 489,024 | 494,377 |
| Add: Depreciation | 5,129 | 4,689 | 10,194 | 8,857 |
| Adjusted EBITDA (non-GAAP) | $50,327 | $46,731 | $81,436 | $77,634 |
| Reconstructive: |
Item 1. Financial Statements
FAQ
- What is Enovis's prevention & recovery — other cost and expense, operating?
- Enovis (ENOV) reported prevention & recovery — other cost and expense, operating of $111.25M in Q2 2026.
- What does prevention & recovery — other cost and expense, operating mean?
- Operating costs incurred by the Prevention & Recovery segment that are not classified as cost of goods sold or research and development, such as administrative overhead, marketing, and sales support. This metric provides insight into the segment's operational efficiency and the cost structure required to support its commercial activities.
Ask your AI about Enovis's prevention & recovery — other cost and expense, operating.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude